MENU

Case Study

Adenosine Signaling in Sickle Cell Disease

Significance

Understanding a disease’s mechanistic pathway is central for novel treatment development. Metabolon’s technology is uniquely positioned to accelerate MOA, identify biomarkers, further personalized medicine and tailor therapy approaches.


Challenge

Sickle cell disease (SCD) is an inheritable hemolytic disorder caused by a single point mutation. Despite knowledge of the molecular defect associated with SCD, mechanism-specific treatment options are lacking.

 

Download Case Study